Home・Aandelen Lijst・AxoGen Inc

AxoGen Inc

Gesloten

SectorGezondheidszorg

49.94 8.14

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

49.7

Max

50.58

Belangrijke statistieken
By Trading Economics
Inkomsten	18M -1.5M
Verkoop	8.3M 70M
EPS	-0.03
Winstmarge	-2.174
Werknemers	622
EBITDA	15M -2.2M

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+9.46% upside

Dividenden
By Acuity
Volgende Winsten	28 okt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	455M 2.6B
Vorige openingsprijs	41.8
Vorige sluitingsprijs	49.94

Nieuwssentiment

By Acuity

67%

33%

307 / 340 Rangschikking in Healthcare

AxoGen Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

21 aug 2026, 20:01 UTC

AxoGen Inc shares are higher today, supported by high trading volume. The stock remains above its 20-day moving average amid broader market gains.

20 aug 2026, 22:46 UTC

AxoGen Inc shares are higher in after-market trading, showing notable strength above the 20-day moving average and near the upper end of its one-month range.

19 aug 2026, 21:01 UTC

AxoGen Inc shares are lower in after-market trading, despite no specific news to explain the decline. The stock remains near its one-month high.

18 aug 2026, 19:16 UTC

AxoGen Inc shares are higher, continuing positive momentum from Monday. The stock remains above its 20-day moving average, reflecting strong performance.

17 aug 2026, 21:01 UTC

AxoGen Inc shares are higher in after-market trading, reaching a peak above Monday's close amid broader market pressures and rising crude oil prices.

14 aug 2026, 20:06 UTC

AxoGen Inc's shares are higher today amid mixed market sentiment following a decline in U.S. retail sales for July. No specific company news was identified.

13 aug 2026, 22:36 UTC

AxoGen Inc. shares declined in after-market trading, despite broader market strength and earlier gains. The stock remains above recent performance averages.

12 aug 2026, 19:32 UTC

AxoGen Inc shares are higher today amid strong trading volume and broader market gains, reflecting optimism from recent inflation data.

10 aug 2026, 19:41 UTC

AxoGen Inc shares are higher, driven by gains in the Health Care Equipment sub-sector and unusually high market volume. The stock remains above its 20-day moving average.

7 aug 2026, 20:05 UTC

AxoGen Inc shares are higher today amid strong market volume, reflecting a broader upward trend since Thursday's close.

5 aug 2026, 19:46 UTC

AxoGen Inc shares are lower amid broader market caution following ADP's report of a significant miss in private sector job growth for July.

4 aug 2026, 20:06 UTC

AxoGen Inc's shares are higher today, continuing a steady climb since Monday's close amid positive market sentiment and broader trends.

3 aug 2026, 20:02 UTC

News

AxoGen Inc. shares are advancing as trading volume spikes amid strong interest. The company reported a 23.1% revenue increase to $69.7 million for Q2 2026.

31 jul 2026, 20:06 UTC

AxoGen Inc shares are higher, recovering from an earlier dip. The stock remains above its 20-day moving average, reflecting solid overall performance.

30 jul 2026, 19:24 UTC

AxoGen Inc shares are higher, supported by significant broader market gains and unusually high trading volume, despite earlier pulling back from session highs.

29 jul 2026, 20:41 UTC

AxoGen Inc shares are lower in after-market trading amid a broader downturn in U.S. equities and rising crude oil prices linked to geopolitical tensions.

28 jul 2026, 20:03 UTC

AxoGen Inc. shares are declining today, pulling back from an earlier high amid broader market weakness linked to declines in Asian indices.

27 jul 2026, 19:16 UTC

AxoGen Inc shares are higher today, continuing a strong upward trend since Friday's close. Broader market sentiment is influenced by declining oil prices.

22 jul 2026, 20:01 UTC

AxoGen Inc shares are lower in Wednesday's session amid high trading volume, continuing a decline that began Tuesday. No specific news was identified.

21 jul 2026, 17:46 UTC

AxoGen Inc shares are higher today, having earlier peaked around 3.01% before pulling back. No specific news was identified to explain the movement.

20 jul 2026, 19:06 UTC

AxoGen Inc. shares are lower during Monday's session, pulling back from earlier highs amid rising Treasury yields and inflation concerns linked to oil prices.

Peer Vergelijking

Prijswijziging

AxoGen Inc Prognose

Koersdoel

By TipRanks

9.46% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 55.17 USD 9.46%

Hoogste 58 USD

Laagste 53 USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor AxoGen Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

6 ratings

Buy

Hold

Sell

Gebaseerd op 6 analisten die aandelenratings hebben gegeven aan AxoGen Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

307 / 340 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over AxoGen Inc

Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. Axogen, Inc. is headquartered in Alachua, Florida.